Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
China flag China · Delayed Price · Currency is CNY
64.90
+0.39 (0.60%)
May 30, 2025, 11:30 AM CST

Hangzhou Alltest Biotech Company Description

Hangzhou Alltest Biotech Co., Ltd. engages in the research, development, production, and sale of in vitro diagnostic reagents in China and internationally.

The company offers rapid diagnostic reagents, including drug and drug abuse, infectious disease, women's health, tumor marker, and cardiac marker testing products.

Its products include COVID-19 antigen and antibody tests; veterinary tests; fluorescence immunoassay tests and analyzers; urine analysis solutions, biochemistry reagents, VTM, blood glucose monitoring systems, and HB hemoglobin test meters.

In addition, the company offers SARS-COV-2 RT-qPCR assays, virus specimen stabilizers, and viral DNA/RNA extraction kits; and other test products.

Its products are used in clinical testing, on-site testing, personal health management, and other fields.

Hangzhou Alltest Biotech Co., Ltd. was founded in 2009 and is based in Hangzhou, China.

Hangzhou Alltest Biotech Co., Ltd.
Country China
Founded 2009
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 969
CEO Fei Gao

Contact Details

Address:
Building 3, 4, 5
Hangzhou, 310018
China
Phone 86 57 1562 07860
Website alltests.com.cn

Stock Details

Ticker Symbol 688606
Exchange Shanghai Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE1000053G6
SIC Code 2835

Key Executives

Name Position
Fei Gao Chairman and GM
Yanping Fu Accounting Supervisor, Chief Financial Officer and Secretary of the Board of Directors
Weike Lu Deputy GM and Director